Based on the Azitra Inc stock forecast from 0 analysts, the average analyst target price for Azitra Inc is not available over the next 12 months. Azitra Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Azitra Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Azitra Inc’s stock price was USD 0.25. Azitra Inc’s stock price has changed by -40.91% over the past week, -40.02% over the past month and -99.46% over the last year.
No recent analyst target price found for Azitra Inc
No recent average analyst rating found for Azitra Inc
Company Overview Azitra Inc
Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut. Read Less
Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinic...Read More
Frequently Asked Questions About Azitra Inc (AZTR) Stock
Stock Target Advisor's fundamental analysis for Azitra Inc's stock is Slightly Bullish .
Unfortunately we do not have enough data on AZTR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AZTR's stock to indicate what its average analyst target is.
AZTR stock's Price/Earning ratio is 0.01.
Our analysis grades AZTR stock's Price / Earning ratio at B-. This means that AZTR stock's Price/Earning ratio is above 20% of the stocks in the Biotechnology sector in the NYE exchange.
Based on this AZTR may be undervalued for its sector.
The last closing price of AZTR's stock was USD 0.25.
The most recent market capitalization for AZTR is USD 3.89M.
Unfortunately we do not have enough analyst data on AZTR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Azitra Inc's stock.
As per our most recent records Azitra Inc has 10 Employees.
Azitra Inc's registered address is 21 Business Park Drive, Branford, CT, United States, 06405.
You can get more information about it from Azitra Inc's website at https://azitrainc.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Azitra Inc (AZTR) Stock
Stock Target Advisor's fundamental analysis for Azitra Inc's stock is Slightly Bullish .
Unfortunately we do not have enough data on AZTR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AZTR's stock to indicate what its average analyst target is.
AZTR stock's Price/Earning ratio is 0.01.
Our analysis grades AZTR stock's Price / Earning ratio at B-. This means that AZTR stock's Price/Earning ratio is above 20% of the stocks in the Biotechnology sector in the NYE exchange.
Based on this AZTR may be undervalued for its sector.
The last closing price of AZTR's stock was USD 0.25.
The most recent market capitalization for AZTR is USD 3.89M.
Unfortunately we do not have enough analyst data on AZTR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Azitra Inc's stock.
As per our most recent records Azitra Inc has 10 Employees.
Azitra Inc's registered address is 21 Business Park Drive, Branford, CT, United States, 06405.
You can get more information about it from Azitra Inc's website at https://azitrainc.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AZTR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
